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Background: Reactive oxygen species (ROS) are important mediators in a number of degenerative diseases.
Oxidative stress refers to the imbalance between the production of ROS and the ability to scavenge these species
through endogenous antioxidant systems. Since antioxidants can inhibit oxidative processes, it becomes relevant to
describe natural compounds with antioxidant properties which may be designed as therapies to decrease oxidative
damage and stimulate endogenous cytoprotective systems. The present study tested the protective effect of two
xanthones isolated from the heartwood of Calophyllum brasilienses against FeSO4-induced toxicity.
Methods: Through combinatory chemistry assays, we evaluated the superoxide (O2
●—), hydroxyl radical (OH●),
hydrogen peroxide (H2O2) and peroxynitrite (ONOO
—) scavenging capacity of jacareubin (xanthone III) and 2-(3,3-
dimethylallyl)-1,3,5,6-tetrahydroxyxanthone (xanthone V). The effect of these xanthones on murine DNA and bovine
serum albumin degradation induced by an OH• generator system was also evaluated. Additionally, we investigated
the effect of these xanthones on ROS production, lipid peroxidation and glutathione reductase (GR) activity in
FeSO4-exposed brain, liver and lung rat homogenates.
Results: Xanthone V exhibited a better scavenging capacity for O2
●—, ONOO- and OH● than xanthone III, although
both xanthones were unable to trap H2O2. Additionally, xanthones III and V prevented the albumin and DNA
degradation induced by the OH● generator system. Lipid peroxidation and ROS production evoked by FeSO4 were
decreased by both xanthones in all tissues tested. Xanthones III and V also prevented the GR activity depletion
induced by pro-oxidant activity only in the brain.
Conclusions: Altogether, the collected evidence suggests that xanthones can play a role as potential agents to
attenuate the oxidative damage produced by different pro-oxidants.
Keywords: Xanthones, Antioxidant capacity, ROS production* Correspondence: veped@yahoo.com.mx; monica.atorres@gmail.com
1Departamento de Neuroquímica, Instituto Nacional de Neurología y
Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., México, DF
14269, México
Full list of author information is available at the end of the article
© 2013 Blanco-Ayala et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
bc
a
Figure 1 Chemical structures of xanthones: a) jacareubin (III), b)
2-(3,3-dimethylallyl)-1,3,5,6-tetrahydroxyxanthone (V), and
c) α-mangostin.
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Redox homeostasis is maintained in organisms as an
intracellular equilibrium between oxidant and antioxi-
dant levels. An imbalance in favor of pro-oxidants re-
sults in oxidative stress which leads cells to damage
through the alteration of endogenous macromolecules
such as proteins, lipids and DNA [1,2]. Cells possess sev-
eral antioxidant defense mechanisms designed to main-
tain homeostasis in response to oxidative stressors;
however, under pathological conditions, such antioxi-
dant defenses are depleted, thus eliciting oxidative
damage. The most promising strategy to prevent the
oxidative damage caused by reactive oxygen and nitro-
gen species (ROS/RNS) is the use of antioxidant mole-
cules. These compounds can act either as direct antioxidant
through free radical scavenging mechanisms or as indirect
antioxidants by enhancing the antioxidant status toward
both enzymatic and non-enzymatic systems. Different nat-
ural compounds have been described as antioxidants, as
they are capable to decrease ROS levels in cells and are
consequently useful to attenuate aging-related complica-
tions [3,4] and for treatment of some human diseases,
including atherosclerosis, cardiovascular diseases [5],
inflammatory injury [6], cancer [7] and neurodegenera-
tive diseases [8]. Natural antioxidants can therefore serve
as innovative tools for preventive medicine. Calophyllum
brasiliense Cambess is a big tree found in the tropical
rain forests from Brazil to Mexico. It has been widely
used in Latin American folk medicine to treat a variety
of maladies including pain [9], inflammation, diabetes,
hypertension [10,11], diarrhea, herpes and rheumatism
[12]. Despite its extensive use, only a few biological ac-
tivities have been reported in the scientific literature.
Plants of this species are a rich source of xanthones
and coumarins. Particularly, xanthones (9H-xanthen-9-
ones) are heterocyclic compounds with the dibenzo-γ-
pyrone framework (Figure 1) [13]. Several xanthones
have been isolated from Calophyllum brasiliense heartwood,
including jacareubin (III) and 2-(3,3-dimethylallyl)-1,3,5,6-
tetrahydroxyxanthone (V). Xanthones from Callophyllum
brasiliense Cambess have shown to be inhibitors
of sulfotransferases, SULT1A1 and SULT2A1 [14], an-
tibiotics [15], and inhibitors of gastric H+, K+−ATPase
activity [16]. Furthermore, it has been reported that
xanthones from other sources, like α-mangostin, are ef-
fective antioxidants and could be important free radical
scavengers [17-21]. This study was conducted to explore the
scavenging effects and antioxidant properties of xanthones
III and V (Figure 1b and 1c, respectively) isolated from
Callophylum brasiliensis, a species collected in the Mexican
rain forest. Here, we evaluated the activities of these xan-
thones as scavengers of different ROS in synthetic systems.
Also, we tested their effects against oxidative damage in-
duced by FeSO4 in brain, liver and lung rat homogenates.Methods
Reagents
Calophyllum brasiliense Cambess (Clusiaceae) was col-
lected by J.I. Calzada from the Selva Lancandona, Chiapas,
México [22]. Identification was done by the collector, a
voucher (JIC-3116), and wood simple (00011-XALw) are
deposited in the Xal Herbarium, and Dr. Faustino Mi-
randa Xylarium, both of the Instituto de Ecología, A.C., at
Xalapa, Ver. México. Five xanthones (I-V) were isolated
from Calophyllum brasiliense heartwood; xanthones III
and V were obtained from a methanolic extract and were
the most abundant constituents, as previously described,
and identified by proton nuclear magnetic resonance and
mass spectrometry [23]. α-Mangostin was isolated from
the dried pericarp of Garcinia mangostana, as previously
described by Marquez-Valadez et al. [24].
2′,7′-dichlorofluorescein (DCF), 2′,7′-dichlorodihydro-
fluorescein diacetate (DCFH-DA), FeSO4, ascorbic acid,
histidine, xylenol orange, ammonium iron (II) sulfate hexa-
hydrate, 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), bovine serum
albumin (BSA), dimethylsulfoxide (DMSO), DL-penicillamine,
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methosulfate (PMS), ethylenediaminetetraacetic acid (EDTA),
nicotinamide adenine dinucleotide (NADH), N-acetyl cysteine
(NAC), N-2-hydroxyethyl-piperazine-N'-2-ethane sulphonic
acid (HEPES), diethylenetriaminepentaacetic acid (DTPA),
nicotinamide adenine dinucleotide reduced form (NADPH),
Coomassie brilliant blue R, mercaptoethanol, bromophenol
blue, sodium dodecyl sulfate (SDS), sodium hypochlorite
(NaOCl), hydrogen peroxide (H2O2) and N,N-dimethyl-4-
nitrosoaniline (DMNA) were all obtained from Sigma Al-
drich Chemical Company (St. Louis, MO, USA). All other
reagents were analytical grade and obtained from known
commercial suppliers. Solutions were prepared using de-
ionized water obtained from a Milli-RQ (Millipore) purifier
system.Animals
Tissue samples were obtained from the whole brain of
male Wistar rats (280–320 g) from the vivarium of
Facultad de Medicina (UNAM, Mexico City). A total
of 40 rats were employed throughout the study. Before
they were subjected to experimental treatments, animals
were housed five per cage in acrylic cages and provided
with standard commercial rat diet (Laboratory rodent diet
5001, PMI Feeds Inc., Richmond, IN, USA) and water ad
libitum. Housing room was maintained under constant
conditions of temperature (25 ± 3°C), humidity (50 ± 10%)
and lighting (12 h light/dark cycles). Tissues were col-
lected by decapitation and immediately dissected out on
ice and preserved for limited times at −70°C. All proce-
dures with animals were carried out according to the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals and the local guidelines on
the ethical use of animals from the Health Ministry of
Mexico. During the dissections, all efforts were made
to minimize animal suffering. The study was approved
by Instituto Nacional de Neurología y Neurocirugía’s
ethics committee (30/12).Superoxide anion scavenging assessment
Superoxide (O2
●—) scavenging was assessed according to
previously reported methods [25] based on the reduction
of NBT. The non-enzymatic PMS/NADH system gener-
ates superoxide radicals that reduce NBT into a purple-
colored formazan. The reaction mixture contained HEPES
buffer (20 mM, pH 7.4), 196 μM NADH, 39.2 μM NBT,
3.92 μM PMS and increasing concentrations of Xanthone
III or V (0 – 1,000 μM). Final mixture volume was
1.3 mL. After incubation for 5 min at room temperature,
the absorbance was taken at 560 nm against an appropri-
ate blank solution. All tests were performed six times in
an independent manner. Results are shown as percent of
O2
●— scavenging capacity.Hydroxyl radical (OH●) scavenging assay
The ability of xanthones III and V to scavenge OH● was
estimated through the Fe3+-EDTA-H2O2-deoxyribose
system [26,27]. The system contained different concen-
trations of xanthones III or V (0 – 50 μM or an equiva-
lent volume of vehicle (ethanol, 0.025% final concentration
used in the assay)) or distilled water for the control),
0.2 mM ascorbic acid, 0.2 mM FeCl3, 0.208 mM EDTA,
1 mM H2O2, 0.56 mM deoxyribose, and 20 mM phosphate
buffer (pH 7.4). OH● radicals were generated by incubating
the mixture (final volume 1 mL) at 37°C for 60 min. The
iron salt (FeCl3) was mixed with EDTA before its addition
to the reaction mixture. The extent of deoxyribose degrad-
ation by the formed OH● was measured directly in the
aqueous phase by the thiobarbituric acid (TBA) test.
Briefly, 100 μL of the 0.05 M TBA solution was added to
the samples and final solutions were re-incubated in a boil-
ing water bath (94°C) for 10 min. The optical density was
estimated at a wavelength of 532 nm in a Genesys 8
spectrophotometer.
Peroxynitrite (ONOO—) scavenging activity assessment
ONOO— was synthesized as previously described [28].
Briefly, 5 mL of an acidic solution (0.6 M HCl) of H2O2
(0.7 M) was mixed with 5 mL of 0.6 M KNO2 on an ice bath
for 1 second, and the reaction mixture was quenched with
5 mL of ice-cold 1.2 M NaOH. Residual H2O2 was removed
using granular MnO2 prewashed with 1.2 M NaOH, and
this mixture was then left overnight at −20°C. The resulting
yellow liquid layer on the top of the frozen mixture was col-
lected for the experiment. Concentrations of ONOO— were
determined before each experiment at 302 nm using a molar
extinction coefficient of 1,670 M-1 cm-1. ONOO— scaven-
ging activity was measured by monitoring the oxidation of
DCFH-DA to DCF by the modified method of Beckman
and Crow [28,29]. The reaction mixture (in a final volume
of 1.45 mL in 0.1 M phosphate buffer pH 7.4) consisted of
14 μM DTPA plus 36.2 μMDCFH-DA plus the samples ex-
posed to different xanthones III and V at increasing concen-
trations (0–1,000 μM) and 35 μM ONOO—. The optical
density was determined at 500 nm in a Genesys 8 spectro-
photometer. A probe containing the reaction mixture, but
not a sample, was considered as 0% scavenging capacity or
100% of DCFH-DA oxidation by the ONOO— added to the
assay. To calculate the ONOO— scavenging ability, the read-
ings of the tubes containing the xanthones or reference
compounds were expressed as percentages of DCFH-DA
oxidation and converted to percentages of scavenging
ability, using as reference the tube with 100% DCFH-
DA oxidation [26].
H2O2 assay
The ability of xanthones III or V to scavenge H2O2 was
measured by the method described by Long et al. [30].
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in HPLC-grade methanol were mixed with 1 volume of
1 mM xylenol orange and 2.56 mM ammonium ferrous
sulfate in 0.25 M H2SO4 to give the "working" FOX re-
agent. A solution of 75 μM H2O2 was mixed with differ-
ent concentrations of xanthones III and V (0–1000 μM)
and added with 0.01 mL of HPLC-grade methanol, im-
mediately followed by the addition of 0.9 mL of FOX re-
agent, vortexed for 5 seconds, and then incubated at
room temperature for 30 min (final volume 1.3 mL).
Tubes were centrifuged at 15,000 × g for 10 min and ab-
sorbance was read at 560 nm against a methanol blank.
OH●-mediated protein degradation
Experiments for detection of OH●-mediated BSA oxida-
tion were carried out using a metal-catalyzed reaction
based on the method described by Kocha et al. [31] with
modifications. A solution of ascorbic acid (1.6 mM)/
EDTA (0.8 mM)/(NH4)2Fe(SO4)2 (0.8 mM) was prepared
in 50 mM phosphate buffer (pH 7.4). Briefly, 1% BSA and
250 μL of the ascorbic acid/EDTA/(NH4)2Fe(SO4)2•6H2O
solution were mixed in the presence or absence of xan-
thones III and V or α-mangostin (0.5, 1 and 2.5 μM). The
generation of OH● was initiated through the addition of
15 μL of 2% H2O2. In control tubes (without the OH
●
generator system), H2O2 was replaced by water. The final
volume for all probes was 250 μL. The maximum concen-
tration of EtOH (vehicle) in reaction tube was 0.01%. After
1 h of incubation at room temperature, 250 μL of 20%
trichloroacetic acid was added, and the mixture was then
centrifuged at 2,236 x g for 30 min at 4°C. The superna-
tants were discarded and the pellets were resuspended in
500 μL of 0.1 M NaOH. To evaluate the oxidative damage
to proteins induced by OH●, the samples were subjected
to SDS-polyacrilamide gel electrophoresis. BSA (50 μg;
from resuspended pellets) was mixed (1:1) with loading
buffer (10% glycerol, 2% SDS, 25 mM Tris–HCl (pH 6.8),
5% mercaptoethanol, 0.1% bromophenol blue) and heated
at 100°C for 1 min. The protein sample (40 μg per well)
was loaded in a 12% polyacrylamide gel and the electro-
phoresis was run at 150 V for 1 h. After running out, gels
were stained with 0.2% Coomassie brilliant blue R for 1 h.
Images were visualized and captured in a BioRad Gel
Documentation System (Gel Doc 1000 BioRad). Protein
levels were densitometrically evaluated using the Quantity
One Program 4.2 [32].
OH●-mediated DNA degradation
DNA samples were obtained from mice tails and incu-
bated overnight at 55°C in lysis buffer (Tris 100 mM,
pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl and
100 μg/ml proteinase K). The mixtures were deproteinized
with phenol:chlorophorm:isoamilic ethanol (25:24:1). The
DNA in the recovered supernatant was precipitated byadding cold isopropanol and washed with 70% ethanol so-
lution, then dissolved in endonucleases-free water for the
assay. Experiments for detection of OH●-mediated DNA
oxidation were carried out by using a metal-catalyzed re-
action based on Kocha et al. [31] with modifications. A so-
lution of ascorbic acid (1.6 mM)/EDTA (0.8 mM)/(NH4)
2Fe(SO4)2 (0.8 mM) was prepared in 20 mM phosphate
buffer (pH 7.4) plus DNA, xanthones III or xanthone V,
and α-mangostin (0.5, 1 and 2.5 μM). Briefly, 20 μg of
purified DNA was mixed with 25 μL of the ascorbic acid/
EDTA/(NH4)2Fe(SO4)2•6H2O solution, in presence or ab-
sence of xanthones and α-mangostin. The generation of
OH● was initiated through the addition of 15 μl of 2%
H2O2. In control tubes (without the OH
● generator sys-
tem), H2O2 was replaced by water. The final volume for
all probes was 250 μL. The maximum concentration of
EtOH (vehicle) in reaction tube was 0.01%. After 15 min
of incubation at room temperature, 50 μL of loading
buffer was added to stop the reaction. To evaluate the
oxidative damage to DNA induced by OH●, 10 μL of
the samples were subjected to agarose (2%) gel electro-
phoresis for 20 min at 90 V. After running out, gels
were stained with ethidium bromide (0.1 mg/ml). Im-
ages were visualized and captured in a BioRad Gel
Documentation System (Gel Doc 1000 BioRad). In
order to estimate DNA degradation; the main DNA
band per well was densitometrically evaluated using
the Quantity One Program 4.2 [32].
Assay of lipid peroxidation
Lipid peroxidation (LP) was assessed in homogenates of
different tissues (brain, liver and kidney) by estimation of
TBA-reactive substances (TBA-RS), according to a previ-
ous report [33]. Each tissue was homogenized (brain 1:10,
liver 1:300, kidney 1:100 w/v) in Krebs buffer (pH 7.4)
containing 19 mM NaCl, 5 mM KCl, 2 mM CaCl2,
1.2 mM MgSO4, 5 mM glucose, 13 mM NaH2PO4 and
3 mM Na2HPO4. Aliquots of 250 μL of the homogenate
were incubated in the presence of FeSO4 (5 μM) and/or
xanthone III and V (0.5, 1 and 2.5 μM). The final vol-
ume for all probes was 500 μL. All incubations were
done at 37°C for 2 h in a shaking water bath. At the
end of the incubation time, 500 μL of the TBA reagent
(containing 0.75 g of TBA + 15 g of trichloroacetic
acid + 2.54 mL of HCl) were added and final solutions
were re-incubated in a boiling water bath (94°C) for
additional 20 min. Samples were then kept on ice for
5 min and centrifuged at 3,000 x g for 15 min. The op-
tical density of supernatants was estimated at a wave-
length of 532 nm in a Genesys 8 spectrophotometer.
Concentrations of malondialdehyde (MDA) were cal-
culated by interpolation in a standard curve of MDA,
constructed in parallel. Results were expressed as per-
cent of LP vs. control.
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ROS were detected by DCF fluorescence [34,35]. Ali-
quots (500 μL) of the homogenates (brain, liver and kid-
ney) were incubated in the absence (control) or presence
of 5 μM FeSO4 and/or xanthones III or V (0.5, 1 and
2.5 μM) at 37°C in a shaking-water bath for 2 h. The
final volume for all probes was 1 mL. Then 100 μL of
75 μM DCF were added to samples and incubated for
30 min in the abscence of light. Finally, samples were
centrifuged at 6,000 x g for 15 min. ROS were convention-
ally detected in supernatants by fluorescent spectrometry
in a Perkin-Elmer LS50 spectrometer at 488 nm (excitation
wavelength) and 532 nm (emission wavelength). Results
were expressed as percent of ROS formation vs. control.
Glutathione reductase (GR) activity
GR activity in forebrain, liver and kidney homogenates was
assayed using oxidized glutathione (GSSG) as substrate and
measuring the consumption of NADPH at 340 nm [36].
Briefly, aliquots of 250 μL of the homogenate were incu-
bated in the presence of 5 μM FeSO4 and/or xanthone III
and V (0.5, 1 and 2.5 μM). The final volume for all probes
was 500 μL. All incubations were done at 37°C for 2 h in a
shaking water bath. After incubation 50 μL of homogenate
were mixed with 950 μL of the reaction mixture (1.25 mM
GSSG, 0.1 mM NADPH, 0.5 mM Na2EDTA in 100 mM
phosphate buffer, pH 7.6). One unit of GR was defined as
the amount of enzyme that oxidizes 1 μmol NADPH/min.
Data were obtained as units per milligram of protein and
expressed as percent of GR activity vs. control.
Statistical analysis
Results were expressed as mean values ± S.E.M. ROS scaven-
ging capacity was expressed as 50% of the inhibitory concen-
tration (IC50) value, which denotes the concentration of the
xanthone and standard (μM) required to reach a 50% reduc-
tion in the respective molecule oxidation relative to the probe
without xanthones or reference compound. IC50 was calcu-
lated by the least square method. The lower the IC50 value
the higher the scavenging capacity of the compound. In re-
gard to the experiments carried out in tissue homogenates,
n = 6 experiments (each experiment corresponding to one rat)
were considered. All data were analyzed by one-way ANOVA
followed by Tukey’s test for multiple comparisons, using the
Prism 3.02 software (GraphPad, San Diego, CA, USA). Values
of P < 0.05 were considered as statistically significant.
Results
Scavenging activities of xanthones III and V
Xanthones III and V were able to scavenge O2
•−
(Figure 2A), OH● (Figure 2B) and ONOO- (Figure 2C)
in a concentration-dependent manner, in contrast,
they were unable to scavenge H2O2 (data not shown).
The IC50 values, calculated from the linear portion ofthe dose–response curve, are shown in Table 1. All
these values are in the μM range. Xanthone V was
more effective to scavenge ROS than xanthone III.
Xanthones III and V prevent the oxidative protein
degradation in a concentration-dependent manner
Xanthones III and V (0.5, 1 and 2.5 μM; Figure 3) were able
to prevent, in a concentration-dependent manner, the BSA
degradation induced by OH●. A densitometric assessment
was employed for protein detection. Protection was found
since the lowest concentration of each xanthone used
(0.5 μM), although this protection was more evident at
higher concentrations (1 and 2.5 μM; Figures 3a and 3b).
The EtOH did not have effect in the DNA degradation in-
duced by OH● (Figure 4c; line 3). These data confirm previ-
ous observations on the OH●-scavenging capacity of
xanthones. α-Mangostin prevented BSA degradation
induced by OH● at all concentrations used.
Xanthones III and V block DNA degradation induced by OH•
Figure 4a shows the protective effect of xanthones III
(lanes 7–9) and V (lanes 10–12) on DNA degradation
induced by OH● (lane 6). The effect of α-mangostin was
also evaluated in this paradigm (lanes 13–15), as a refer-
ence. The OH● generator system induced around 35% of
DNA degradation (Figure 4b), which was completely
abolished by xanthones III and V and α-mangostin, an
effect not dependent of the concentration used. Figure 4c
shows that the three compounds tested did not exert
any effect when compared to control group at the
highest concentration used (2.5 μM; lanes 3, 4 and 5)
and also shows that the EtOH at the maximum concen-
tration used (0.01%) does not have any effect on the
DNA degradation induced by OH• (line 11).
Xanthones III and V reduce the ROS production induced
by FeSO4
FeSO4 induced an increase in ROS formation in fore-
brain, liver and kidney (186.7% 380%, and 380.3% when
compared to control group, respectively (Figures 5 and
6a, 5 and 6b and 5 and 6c). In all preparations, xan-
thones III and V (0.5, 1 and 2.5 μM; Figures 5 and 6, re-
spectively) reduced ROS formation to basal levels and
also decreased ROS formation in a concentration-
dependent manner in the homogenates exposed to
the ferrous iron. Upon these conditions, ethanol (used
as vehicle) did not have any effect when compared to
control group. Both xanthones showed the same ef-
fectiveness to decrease this marker.
Xanthones III and V reduced the lipid peroxidation
produced by FeSO4
Figures 7 and 8 show the FeSO4-induced increase in
LP in homogenates of (a) forebrain, (b) liver and (c)

















































































Figure 2 Xanthones III and V are able to scavenge (a) O2
•−, (b) OH● and (c) ONOO− in a concentration-dependent manner. In vitro
systems of ROS production were assessed and subjected to different concentrations of xanthones (0.5-1,000 μM). Both xanthones showed an
effective capacity as scavengers of O2
•−, OH● and ONOO−. Data are presented as mean values ± S.E.M. of seven experiments per group.
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control group, respectively). Xanthones III and V de-
creased the FeSO4-induced LP in a concentration-
dependent manner in all tissue homogenates tested(Figures 7 and 8, respectively). In addition, the incu-
bation with vehicle alone did not exert any effect on
this marker. However, both xanthones III and V re-
duced lipid peroxidation at the highest concentration
Table 1 ROS scavenging ability of xanthones III and V
O2
•— OH● ONOO—
Xanthone III 336.5 ± 8.9 1.82 ± 0.06 63.6 ± 11.6
Xanthone V 262.4 ± 7.7 0.07 ± 0.003 29.6 ± 6.8
Values are expressed as IC50 (μM).
Data are mean ± S.E.M. of six experiments per group. OH●: hydroxyl radicals,
O2
●— : superoxide anion, ONOO— : peroxynitrite anion.


















C    X-lll   X-V  M         0.5    1
X-
c
Figure 3 Protective effect of xanthones III and V on bovine serum alb
Representative Coomassie blue-stained-BSA gel is shown. Different concen
mangostin (M) were tested in OH● generator system. b) Quantitative repre
stained-BSA gel is shown. Lane 1, BSA; lane 2, OH● + BSA; lane 3, EtOH (0.0
(2.5 μM) respectively. + BSA + OH●. Data are presented as mean ± S.E.M. of
OH●, cP < 0.01 vs. α-mangostin.
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forebrain and liver homogenates.
Xanthone III and V prevent the reduction of glutathione
reductase activity induced by FeSO4
In brain homogenates, xanthones III and V prevented
the decrease in GR activity generated by FeSO4 (~ 50%
of reduction when compared to control group; Figure 9).
In liver and kidney homogenates, ferrous iron did not2.5 0.5 1 2.5 0.5 1 2.5
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umin (BSA) oxidation induced by an OH● generation system. a)
trations (0.5, 1 and 2.5 μM) of xanthones III (X-III) and V (X-V) and α-
sentation of the BSA detection. c) Representative Coomassie blue-
1%) + BSA + OH●; lanes 4, 5 and 6, xanthones III, V and α-mangostin
4 independent experiments. aP < 0.01 vs. Control (C), bP < 0.01 vs. BSA +
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Figure 4 Xanthones exerted a protective effect on DNA oxidation induced by an OH● generation system. a) Representative ethidium
bromide stained DNA-agarose gel. Lane 1, molecular weight markers; lane 2, DNA (20 μg); lane 3, xanthone III (2.5 μM); lane 4, xanthone V
(2.5 μM); lane 5, α-mangostin (2.5 μM); lane 6, DNA (20 μg) + OH●; lanes 7–9 DNA (20 μg) + OH● + xanthone III (0.5, 1 and 2.5 μM, respectively);
lane 10–12 DNA (20 μg) + OH● + xanthone V (0.5, 1 and 2.5 μM, respectively); lanes 13–15, DNA (20 μg) + OH● + α-mangostin (0.5, 1 and 2.5 μM,
respectively). b) Quantitative representation of the DNA detection. c) Representative ethidium bromide stained DNA-agarose gel. Lane 1,
molecular weight markers; lane 2, DNA (20 μg); lane 3, xanthone III (2.5 μM); lane 4, xanthone V (2.5 μM); lane 5, α-mangostin (2.5 μM); lane 6,
EtOH; lanes 7, DNA (20 μg) + OH●; lane 8, DNA (20 μg) + OH● + xanthone III (2.5 μM); lane 9, DNA (20 μg) + OH● + xanthone V (2.5 μM); lanes 10,
DNA (20 μg) + OH● + α-mangostin (2.5 μM) and lane 11, DNA (20 μg) + OH● + EtOH. Data are presented as mean ± S.E.M of 4 independent
experiments. aP < 0.01 vs. Control, bP < 0.01 vs. DNA + OH●.
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http://www.biomedcentral.com/1472-6882/13/262have any effect in GR activity (data not shown). The ve-
hicle alone showed no effects.
Discussion
Several properties have been described for compounds
derived from Calophyllum brasiliense Cambess [9,10,16].
Specially, xanthones exhibit diverse biological properties,
including antihypertensive, antioxidative, antithrombotic
and anticancer activities [37,38]. The xanthone nucleus
is known as 9-xanthenone or dibenzo-γ-pyrone [39-41]
and its biological activity depends on specific substitu-
ents and their positions to the basic structure in the ring
system of each molecule [37]. The xanthones used here,
III and V, are the most abundant extracted from the
heartwood of C. brasiliense. In the present study, novel
findings on ROS scavenging activity and protective ef-
fects were described for the antioxidant compounds xan-
thones III and V. Here, we found that both xanthoneswere able to scavenge O2
●—, OH● and ONOO-; under
our assay conditions. It has been reported that glutathi-
one show a higher IC50 for superoxide (2,171.5 μM) than
the both xanthones employed in this work [42], and also
we demonstrated that these xanthones are better OH• –
scavenger than α-mangostin (IC50: 8000 μM) [19,43].
Noteworthy, xanthone V showed a lower IC50 than xan-
thone III in all the synthetic scavenging assays. This ef-
fect could be due to the fact that xanthone V has an
extra hydroxyl group in C-3 compared to xanthone III.
Several authors have reported that the presence of hy-
droxyl groups is an important factor for their functionality
[16,44,45]. The scavenging capacity of these xanthones is
notorious since it has been widely reported that excessive
amounts of ROS can affect, in a direct or indirect manner,
some essential biomolecules such as DNA, proteins and
lipids, further leading to cell death either through necrosis
or apoptosis [46]. Also, this scavenging capacity supports








































































































Figure 5 Effect of xanthone III on the ROS production induced by FeSO4 in homogenates of different tissues. a) Forebrain, b) liver and
c) kidney homogenates were incubated with 5 μM FeSO4 and different concentrations on xanthone III (0 – 2.5 μM) in Kreb’s buffer. Control is
represented by 100% and EtOH (50%) was used as a vehicle to dissolve xanthones. In all panels, mean values ± S.E.M. of six experiments per
group are shown. aP < 0.01 vs. control; bP < 0.01 vs. FeSO4.
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http://www.biomedcentral.com/1472-6882/13/262the previous hypothesis postulated by Reyes-Chilpa [23],
in which he proposed that xanthones III and V prevent
the wood degradation by brown rot fungi that involvessecretion of fungal H2O2 and its interactions with wood
Fe2+ ions through their antioxidant and free radical scav-
enging properties.









































































































Figure 6 Effect of xanthone V on the ROS production induced by FeSO4 in homogenates of different tissues. a) Forebrain, b) liver and
c) kidney homogenates were incubated with 5 μM FeSO4 and different concentrations on xanthone V (0 – 2.5 μM) in Kreb’s buffer. Control is
represented by 100%. In all panels, mean values ± S.E.M. of six experiments per group are shown. aP < 0.01 vs. control; bP < 0.01 vs. FeSO4.
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http://www.biomedcentral.com/1472-6882/13/262We also showed that BSA and DNA degradation were
prevented by both xanthones III and V, exhibiting the
same efficacy than α-mangostin to prevent these changes.
The degradation of BSA and DNA was promoted by the
Fenton reaction, supporting the concept that plasma
concentrations of transition metals such as copper oriron, can increase with age as well as in some patholo-
gies such as diabetes. These metals readily catalyze re-
actions related to the formation of H2O2 through the
Fenton reaction to form OH●, the most powerful oxi-
dizing species able to interact directly with DNA and
proteins.






































































































Figure 7 Xanthone III decreased lipid peroxidation (LP) induce by FeSO4. Different concentrations of xanthone III (0.5, 1, 2.5 μM) were
incubated in the presence of ferrous iron in a) forebrain, b) liver and c) kidney homogenates. Control is represented by 100%. Data are presented
as mean values ± S.E.M. of six experiments per group. aP < 0.01 control; bP < 0.01 vs. FeSO4.
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http://www.biomedcentral.com/1472-6882/13/262Due to the scavenging capacity exerted by xanthones
III and V, the potential protective effect of these mole-
cules against FeSO4 was further studied in homogenatesfrom rat brain, liver and kidney to elucidate if the pro-
tective effect depends of the nature of the tested tissue.
Here we show that xanthones III and V can prevent an








































































































Figure 8 Concentration-response effect of xanthone V on the lipid peroxidation (LP) induced by FeSO4 in homogenates. a) Forebrain,
b) liver and c) kidney homogenates were incubated with 5 μM FeSO4 and different concentrations of xanthone V (0, 0.5, 1 and 2.5 μM) in Kreb’s
buffer. Control is represented by 100%. In all panels, mean values ± S.E.M. of six experiments per group are shown. aP < 0.01 vs. control; bP < 0.01
vs. FeSO4.
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http://www.biomedcentral.com/1472-6882/13/262increase in the levels of the oxidative markers tested,
which in turn are related with the scavenging capacity
exhibited by these xanthones in synthetic assays.Interestingly, the antioxidant effect showed by xan-
thones on ROS production and lipid peroxidation was
not dependent on the tissue studied. Moreover, only in




























Figure 9 Xanthones III and V prevented the glutathione reductase (GR) activity reduction induced by FeSO4 in brain
homogenates. Forebrain homogenates were incubated with 5 μM FeSO4 and 2.5 μM xanthones III or V in Kreb’s buffer. Control is
represented by 100%. Mean values ± S.E.M. of three experiments per group are shown. The data are represented as a percentage with
respect to control. aP < 0.01 vs control; bP < 0.01vs. FeSO4.
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activity, and this effect was prevented by both xan-
thones. The fact that these xanthones can modulate the
GR activity in the brain after the pro-oxidant insult was
applied is relevant since the brain is known to be par-
ticularly vulnerable to oxidative damage due to its high
rate of oxidative metabolic activity, high polyunsaturated
fatty acid content, relatively low antioxidant capacity and
inadequate neuronal cell repair activity [47]. In this con-
text, GSH is considered the most important endogenous
antioxidant in the brain, and GR plays an important role
for the conversion of GSSG to GSH. Thus, the evidence
collected here suggests that xanthones III and V can be
considered as effective antioxidants since they can re-
cover GR activity and were more efficient to scavenge
O2
●— than GSH [42]. Thus, since it has been described
that different xanthones can modulate a number of
physiological molecules [6,14,16], our results suggest
that the brain GR can also be a molecular target for xan-
thone III and V.
Considering that the tested xanthones can exert a pro-
tective action on some biomolecules from the oxidative
damage in the same magnitude than α-mangostin, it is
desirable to elucidate specific mechanisms and targets
by which these molecules exert their protection, thereby
raising expectations on its potential use for therapeutic
purposes. Particularly, our group and others have made
important descriptions on the properties of α-mangostin, a
well-known xanthone derived from the pericarp of mango-
steen fruit, which has antioxidant and anti-inflammatory
properties [19,21,24,48-51]. This typically oriental product
contrast with the endemic location of Calophyllum
brasiliense Cambess, a species geographically located
in Latin America. Therefore, the latter constitutes analternative source of xanthones to be studied and used
in alternative medicine around the Occidental hemi-
sphere. Particularly, our study raises considerations on
xanthones to be considered as an innovative tool with po-
tential benefits for treatment of those diseases coursing
with oxidative stress.
Conclusions
In summary, this work provides evidence that the natural
xanthones III and V possess potential antioxidant proper-
ties, although the antioxidant mechanisms through which
they exert their actions need to be explored in detail in
further studies.
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